RI (RAGE Inhibitor) Study

There is something you can do today that may help treat Alzheimer’s disease tomorrow

If you or family members are living with the beginning stages of Alzheimer’s disease, you can help untangle its mystery. Researchers are looking for people with mild to moderate Alzheimer’s disease to help discover whether an experimental drug, called a RAGE inhibitor (RI), may help treat memory loss. You’ll help advance the understanding of Alzheimer’s disease through a clinical trial, the RI Study, carefully monitored by a team of doctors and nurses at a research center near you.

The RI Study seeks volunteers who:

• Are age 50 or older
• Have been diagnosed as having probable Alzheimer’s disease or dementia
• Have a caregiver or family member who can accompany the participant to each study visit
• Are currently taking AD medication (Aricept, Exelon, or Razadyne)
• Do not have Type 1 or Type 2 diabetes

For more information or to find a study site, click on the links below.

Full description and list of study sites

More information about the RI study:

• Brochure text only (MS Word, 31K)

RI print Public Service Announcements (PSAs):

Questions? Read "AD Clinical Trials: Questions & Answers", contact your local RI study site, or contact the ADEAR Center at 1-800-438-4380 or by e-mail.